Glycosylation and metastases
- 25 October 2018
- journal article
- review article
- Published by Wiley in Electrophoresis
- Vol. 40 (1) , 140-150
Abstract
The change of cellular glycosylation is one of the key events in malignant transformation and neoplastic progression, and tumor‐related glycosylation alterations are promising targets in both tumor diagnosis and therapy. Both malignant transformation and neoplastic progression are the consequence of gene expression alterations and alterations in protein expression. Micro environmental factors such as extracellular matrix (ECM) also play an important role in their growth and metastasis. Tumor‐associated glycans are important biomarker candidates for cancer diagnosis and prognosis, and analytical methods for their detection were developed recently. Glycoproteomics that use mass spectrometry for identification of cancer antigens and structural analysis of glycans play a key role in the investigation of changes of glycosylation during malignant transformation and tumor development and metastasis. Deep understanding of glycan remodeling in cancer and the role of glycosyltransferases that are involved in this process will require a detailed profiling of glycosylation patterns of tumor cells, and corresponding analytical methods for their detection were developed.Keywords
This publication has 97 references indexed in Scilit:
- Eukaryotic Initiation Factor 4H Is under Transcriptional Control of p65/NF-κBPLOS ONE, 2013
- Human immunodeficiency virus-1 Tat activates NF-κB via physical interaction with IκB-α and p65Nucleic Acids Research, 2011
- Cancer cell-derived microvesicles induce transformation by transferring tissue transglutaminase and fibronectin to recipient cellsProceedings of the National Academy of Sciences, 2011
- Mucins in cancer: function, prognosis and therapyNature Reviews Cancer, 2009
- Vascular endothelial growth factor receptor-2: Structure, function, intracellular signalling and therapeutic inhibitionCellular Signalling, 2007
- Cell Adhesion Molecules: Potential Therapeutic & Diagnostic ImplicationsMolecular Biotechnology, 2007
- Non-Anticoagulant Heparins and Inhibition of CancerPathophysiology of Haemostasis and Thrombosis, 2007
- Integrin signalling during tumour progressionNature Reviews Molecular Cell Biology, 2004
- Cell adhesion and signalling by cadherins and Ig-CAMs in cancerNature Reviews Cancer, 2004
- Tumour-cell invasion and migration: diversity and escape mechanismsNature Reviews Cancer, 2003